Melbourne School of Population and Global Health, University of Melbourne, Australia.
Melbourne School of Population and Global Health, University of Melbourne, Australia; Population Health Research Institute, McMaster University, Hamilton, Canada.
Prev Med. 2020 Oct;139:106068. doi: 10.1016/j.ypmed.2020.106068. Epub 2020 Mar 16.
We aimed to examine whether a lifestyle intervention was effective in reducing cardiovascular disease (CVD) risk in individuals at high-risk of developing diabetes in a low- and middle-income setting. The Kerala Diabetes Prevention Program was evaluated by a cluster-randomized controlled trial (2013-2016) of 1007 individuals (aged 30-60 years) at high-risk for diabetes (Indian Diabetes Risk Score ≥ 60 and without diabetes) in Kerala state, India. Sixty polling areas in Kerala were randomized to intervention or control groups by an independent statistician using a computer-generated randomization sequence. Participants from 30 intervention communities received a 12-month structured peer-support lifestyle intervention program involving 15 group sessions and linked community activities, aimed at supporting and maintaining lifestyle change. The primary outcome for this analysis was the predicted 10-year CVD risk at two years, assessed using the Framingham Risk Score. The mean age at baseline was 46.0 (SD: 7.5) years, and 47.2% were women. Baseline 10-year CVD risk was similar between study groups. The follow-up rate at two years was 95.7%. The absolute risk reduction in predicted 10-year CVD risk between study groups was 0.69% (95% CI: 0.09% to 1.29%, p=0.024) at one year and 0.69% (95% CI: 0.10% to 1.29%, p=0.023) at two years. The favorable change in CVD risk with the intervention condition was mainly due to the reduction in tobacco use (change index: -0.25, 95% CI: -0.42 to -0.09). Our findings suggest that a community-based peer-support lifestyle intervention could reduce CVD risk in individuals at high-risk of developing diabetes in India. TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Registry ACTRN12611000262909.
我们旨在探讨在中低收入环境下,生活方式干预是否能有效降低有糖尿病发病风险的个体的心血管疾病(CVD)风险。该研究通过在印度喀拉拉邦(Kerala state)开展的一项以人群为基础的、随机对照试验(2013-2016 年)来评估喀拉拉邦糖尿病预防计划(Kerala Diabetes Prevention Program),共纳入 1007 名有糖尿病发病风险(印度糖尿病风险评分≥60 分且无糖尿病)的个体(年龄 30-60 岁)。喀拉拉邦的 60 个投票区由独立的统计学家通过使用计算机生成的随机数序列进行随机分组,分为干预组和对照组。来自 30 个干预社区的参与者接受了为期 12 个月的结构化同伴支持生活方式干预计划,包括 15 次小组会议和相关的社区活动,旨在支持和维持生活方式的改变。本分析的主要结局是两年时使用Framingham 风险评分预测的 10 年 CVD 风险。基线时的平均年龄为 46.0(SD:7.5)岁,47.2%为女性。两组基线时的 10 年 CVD 风险相似。两年时的随访率为 95.7%。两组间预测的 10 年 CVD 风险绝对差值为 0.69%(95%CI:0.09%1.29%,p=0.024),一年时为 0.69%(95%CI:0.10%1.29%,p=0.023)。干预组 CVD 风险的有利变化主要归因于烟草使用的减少(变化指数:-0.25,95%CI:-0.42~-0.09)。我们的研究结果表明,基于社区的同伴支持生活方式干预可以降低印度有糖尿病发病风险个体的 CVD 风险。
澳大利亚和新西兰临床试验注册中心 ACTRN12611000262909。